TheraRadar
Data updated: May 26, 2026

ROPIVACAINE HYDROCHLORIDE

Pain Approved 2014-07-17

Ropivacaine Hydrochloride Injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration. Surgical Anesthesia: epidural block for surgery including cesarean section; major nerve block; local infiltration. Acute Pain Management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration.

Source: FDA Label • INFORLIFE
15
Indications
--
Phase 3 Trials
11
Years on Market

Details

Status
Prescription
First Approved
2014-07-17
Routes
INJECTION
Dosage Forms
SOLUTION, INJECTABLE

ROPIVACAINE HYDROCHLORIDE Approval History

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
151 FDA actions from 2014 to 2025
Aug 2025 SUPPL
Label · Labeling
Mar 2025 ORIGINAL
Update
Mar 2025 SUPPL
Label · Labeling

What ROPIVACAINE HYDROCHLORIDE Treats

15 FDA approvals

Originally approved for its first indication in 2014 . Covers 15 distinct patient populations.

  • Other (15)
📋

Clinical Trial Registry

5 trials
Trial Sponsor ID Phase Status Title
NCT07519109 SYH9089-001 Ph 1 not yet recruiting Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
NCT07353307 TRD303-Ⅲ -02 Ph 3 recruiting A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.
NCT03360214 results posted AAAQ4708 Ph 4 completed PEMF and PEC Blocks in Mastectomy Reconstruction Patients
NCT04368364 results posted HSC-MS-20-0143 Ph 4 terminated A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain
NCT02438852 4B-14-4 NCI-2015-00279, 4B-14-4 Ph 3 withdrawn Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ROPIVACAINE HYDROCHLORIDE FDA Label Details

Indications & Usage

FDA Label (PDF)

Ropivacaine Hydrochloride Injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration. Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration Ropivacaine Hydrochloride is an amide local anesthetic indicated in adults for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia: epidural block for surgery...

Looking for the branded version?

NAROPIN

Full clinical data, patents, trials, and competitive landscape for ropivacaine hydrochloride.

See NAROPIN

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.